CHICAGO – Men and women may not really be all that different when it comes to mild coronary artery disease.
A prospective, multinational registry analysis found that 1.2% of women and 1.1% of men...
With timing that defies coincidence, the American Society of Hypertension (ASH) and International Society of Hypertension (ISH) posted on Dec. 17 new <link...
HOLLYWOOD, FLA. – The relative risk of thromboembolic events is greater in inpatient inflammatory bowel disease patients than in the general population, but prophylactic treatment is still not...
For patients who have resistant hypertension and obstructive sleep apnea, 3 months of treatment with continuous positive airway pressure significantly reduces mean and diastolic blood pressure and...
The American Heart Association has set aside a 5-year, $30-million research fund to dig deeper into two large national studies in hopes of finding more clues to personalized treatment and prevention...
DALLAS – Enhanced pacemaker technology sharply reduced progression of nonpermanent atrial fibrillation to permanent AF in patients with bradycardia and sinus node disease in the large international,...
The cholesterol guideline represents a major change for several reasons. Unlike any previous guidelines in the United States or elsewhere, the cholesterol guideline is truly process oriented and...
Far from reducing the risk of cardiovascular events in patients with recent acute coronary syndrome, the sPLA2 inhibitor varespladib actually raised the risk of MI in an international randomized...
A multifaceted intervention was effective for improving postdischarge medication adherence among patients hospitalized for acute coronary syndrome but had no effect on achievement of blood pressure...